Planing to attend? Save $500 on your ticket with super early-bird pricing ($900) + 3-for-the-price-of-2 group packs available. Offer ends in:
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
The next generation of drug product development
and manufacturing technology is here…
Now in it’s 11th year, the popular 2025 Summit on Innovations in Controlled Release, Bioavailability Enhancement & Continuous Manufacturing returns this May.
Connect with 160+ senior drug development innovators and uncover industry’s latest formulation, product development and delivery technologies for improving performance and manufacuring capabilities.
2025’s Summit covers Controlled & Modified Drug Release, Drug Bioavailability Enhancement and Continuous Manufacturing technologies and capabilities.Â
✅ 2 full tracks of technical talks, panels and thought-provoking discussion sessions
✅ Network with 100’s of senior development, formulation and manufacturing attendees and solution providers
✅ Multiple exhibits, banquet lunches and dinners, workshops, exhibits, champagne giveaways and networking receptions
✅ Access all sessions post-Summit on-demand so you can relive your best moments
✅ Be part of our community of drug product development experts which will open many doors in the future.
40+
Industry-led Speakers
160+
Senior Attendees
2
Tracked Streams
14+
Networking Hours
18
Solution Providers
Controlled and Modified Release
- Oral Drug Delivery Systems
- Long Acting Injectable Drug Delivery Systems
- Transdermal Drug Delivery Systems
- Modified release coating systems
- Biodegradable and Biocompatible Polymers
- Nanotechnology in Controlled Release
- Pulmonary Drug Delivery Systems
- The Role of Controlled Release in Optimizing Therapeutic Outcomes
- Patient Centric / Pediatric Dose Development
- 3D Printing in Controlled and Modified Release
- Regulatory considerations
- Continuous manufacturing of Controlled and Modified Release products
- Continuous modified release coating systems
- Continuous long-acting microsphere manufacturing
Bioavailability Enhancement
- Formulation strategies for improved absorption of poorly soluble and/or poorly permeable drugs
Solubility and dissolution enhancement techniques:
– Lipid-Based formulations
– Micronization
– Nanomedicine
– Nanocarriers
– Spray Dried Dispersions (SDD)
– Hot Melt Extrusion (HME)
– Kinetisol - Biopharmaceutics classification system (BCS) and its implications
- In vitro-in vivo correlations (IVIVCs)
- Continuous manufacturing technologies for Bioavailability Enhancement
Continuous Manufacturing
- Continuous biopharmaceutical manufacturing
- Continuous manufacturing of oral solids
- Spray Drying and Continuous Manufacturing of Pharmaceutical Materials
- Melt Extrusion and Continuous Manufacturing of Pharmaceutical Materials
- Continuous reactors for pharmaceutical manufacturing
- Recent regulatory status in continuous manufacturing
- Continuous Manufacturing equipment change over time
- Capacity planning for continuous pharmaceutical manufacturing facilities
- Continuous modified release coating equipment
- Continuous fluid-bed coating
- Continuous tablet-coating
- Continuous lyophilization
2025 Speakers Include
Ajaz Hussain, PhD
Industrial Consultant & Fmr Deputy Director Office of Pharmaceutical Science
FDA
Feng Zhang, PhD
Assistant Professor in the Division of Molecular Pharmaceutics and Drug Delivery
University of Texas at Austin
Yogesh Bachhav, PhD
Associate Director
AiCuris
Prit Lakhani, PhD
Sr. Principal Scientist, Pharmaceutics and Drug Delivery‬
Bristol-Myers Squibb
Qi-Ying Hu, PhD
Chief Executive Officer
Corti Therapeutics
Ruchit Trivedi, PhD
Director, CMC Pharmaceutics,
Eli Lilly
Debanjan Das, PhD
Senior Associate Director & Science Fellow, R&D
Bayer
Sidd Keshwarni, PhD
Director, Small Molecule CMC Development
Abbvie
Chong-Hui Gu, PhD
Head of CMC and QA
Foghorn Therapeutics, Inc
Fan Meng, PhD
Senior Scientist, Formulation & Drug Delivery
Sanofi
Shabbir Lobo, PhD
Scientist, Global Innovations and Product Development
Bayer
Masih Jaigirdar, PhD
Former Senior Product Quality Reviewer
FDA
Firouz Asgarzadeh, PhD
President of Consulting Services
OSD Pharmaceutical Solutions
Tasneem Gandhi, PhD
Formulation and Process Scientist
Glatt
Erica Schlesinger, PhD
Vice President of Technical Development
Seran Biosciences
Manish Gupta, PhD
Executive Director, Sterile Drug Product Development
GlaxoSmithKline
2025 Sponsors & Exhibitors
Download The Controlled Release Previous Attendee List
Partnering with the 2025 Summit will also help you:
- Enhance commercial relationships with existing clients through platform interaction, meetings, and discussing the latest opportunities
- Raise your brand awareness to a captive and engaging audience, which most-of-all encompasses decision-making criteria
- Elevate your profile amongst industry peers and developing a contact base through 1-2-1 networking sessions
- Generate direct new business opportunities from senior-level attendees with decision-making criteria currently sourcing drug product development solutions
"*" indicates required fields
Registration Pricing:
Super Early-Bird
Register Before February 14, 2025
Regular Attendance
$900
3-for-2 Group Pack
$1800
On-Demand
$595
Early-Bird Rate
Register Before March 22, 2025
Regular Attendance
$1400
3-for-2 Group Pack
$2800
On-Demand
$595
ONSITE PRICING
Register March 22, 2025 Onwards
Regular Attendance
$1600
3-for-2 Group Pack
$3200
On-Demand
$795